Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Clinical trials sponsored by Shaanxi Micot Pharmaceutical Technology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Dual-Target drug aims to beat current therapy for kidney Patients' hormone problem Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Completed 3 Terminated 1

Heart drug trial halted after only 6 patients

Disease control Stopped early

This trial tested a new drug called MT1002 in 6 people having a heart procedure (PCI) after a heart attack. The goal was to see if it could safely control blood clotting. However, the study was stopped early, so we don't have enough information to know if the drug works or is saf…

Phase 2 • Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC